These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2789403)

  • 1. Antithrombin III and plasma substitution in septic shock.
    Seitz R; Wolf M; Egbring R
    Prog Clin Biol Res; 1989; 308():965-9. PubMed ID: 2789403
    [No Abstract]   [Full Text] [Related]  

  • 2. The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution.
    Seitz R; Wolf M; Egbring R; Havemann K
    Eur J Haematol; 1989 Jul; 43(1):22-8. PubMed ID: 2788582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological determination of proteinase inhibitor complexes (PICs) and their behaviour during plasma derivate treatment in septic infections.
    Egbring R; Seitz R; Blanke H; Menges T; Südhoff R; Stober T; Kolb G; Lerch L
    Prog Clin Biol Res; 1989; 308():971-6. PubMed ID: 2789404
    [No Abstract]   [Full Text] [Related]  

  • 4. An acquired antithrombin III deficiency in the course of toxic shock syndrome after elective orthopaedic surgery.
    Henny CP; Knot EA; Ten Cate JW; Peters M; ten Veen JH; Roos J
    Neth J Med; 1983; 26(5):133-7. PubMed ID: 6866173
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible role of the phagocytic proteinases, cathepsin B and elastase, in orthotopic liver transplantation.
    Riess H; Jochum M; Machleidt W; Himmelreich G; Slama R; Steffen R
    Transplant Proc; 1991 Jun; 23(3):1947-8. PubMed ID: 2063438
    [No Abstract]   [Full Text] [Related]  

  • 6. The inactivation of antithrombin III by serum elastase in patients with surgical infections.
    Cohen JR; Sarfati I; Birnbaum E; Benacquista T; Wise L
    Am Surg; 1990 Nov; 56(11):665-7. PubMed ID: 2240857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of antithrombin systems during heparin therapy].
    Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
    Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock.
    Endo S; Inada K; Ceska M; Takakuwa T; Yamada Y; Nakae H; Kasai T; Yamashita H; Taki K; Yoshida M
    J Inflamm; 1995; 45(2):136-42. PubMed ID: 7583359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
    Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
    Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between angiotensinogen, alpha 1-protease inhibitor elastase complex, antithrombin III and C-reactive protein in septic ARDS.
    Hilgenfeldt U; Kellermann W; Kienapfel G; Jochum M
    Eur J Clin Pharmacol; 1990; 38(2):125-31. PubMed ID: 2338108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the elastase burden in patients with idiopathic interstitial pneumonia].
    Kamei T; Fujita J; Yamaji Y; Takahara J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1081-8. PubMed ID: 8255016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of thrombin- and elastase-modified human antithrombin III.
    Gettins P; Harten B
    Biochemistry; 1988 May; 27(10):3634-9. PubMed ID: 3408716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma component therapy: new trends.
    Rudowski WJ; Scharf R
    Surg Annu; 1986; 18():311-26. PubMed ID: 3510468
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical significance of alpha 1-antitrypsin-elastase (alpha 1AT-ELP) and alpha 2-antiplasmin-plasmin (alpha 2AP-PL) complexes for the differentiation of coagulation protein turnover: indications for plasma protein substitution in patients with septicaemia.
    Seitz R; Egbring R; Radtke KP; Wolf M; Fuchs G; Fischer J; Lerch L; Karges HE
    Int J Tissue React; 1985; 7(4):321-8. PubMed ID: 2933357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.
    Taylor FB; Emerson TE; Jordan R; Chang AK; Blick KE
    Circ Shock; 1988 Nov; 26(3):227-35. PubMed ID: 3061681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New plasma components.
    Sherman LA
    Clin Haematol; 1984 Feb; 13(1):17-38. PubMed ID: 6373081
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antithrombin III, alpha 2-macroglobulin, alpha 1-antitrypsin and plasminogen in childhood diabetes].
    Kotschy M; Wasikowa R; Iwanicka Z; Ciosek W
    Pol Tyg Lek; 1984 Apr; 39(18):611-3. PubMed ID: 6085653
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum elastase and its inhibitors in the blood of heavily burnt patients.
    Miskulin M; Moati F; Robert AM; Robert L; Monteil R; Guilbaud J
    J Clin Pathol; 1978 Sep; 31(9):866-71. PubMed ID: 81839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
    Hayakawa M; Sawamura A; Yanagida Y; Sugano M; Hoshino H; Gando S
    Shock; 2008 Dec; 30(6):649-52. PubMed ID: 18496242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.